
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check treating stage 2 blood pressure the morning after a 24-hour ambulatory recording, chlorthalidone with amlodipine as the initial combination, the HFpEF diagnosis (NT-proBNP 480, ejection fraction 62%, E/e' 15, left atrial volume index 38), dapagliflozin, spironolactone for low potassium and blood pressure above target, the missed one- to two-week potassium check, the orthostatic episode in the heat, and moderate-intensity atorvastatin. | ||
| provenance review | not_started | Sources: PBS American Masters, the Zora Neale Hurston Trust (Valerie Boyd's essay and chronology), the University of Florida Smathers Libraries, the Encyclopedia of Alabama, the Florida Department of State and a Library of Congress research guide. The Library of Congress collection pages, Florida Memory, the Smithsonian NMAAHC and the New York Times could not be fetched; Robert Hemenway's and Valerie Boyd's biographies were not read directly. | ||
| safe messaging review | not_started | Poverty, the welfare home and the unmarked grave are recorded plainly as history, without pity or graphic detail. No mental health claim is made; mood screening is synthetic and negative. No relative or other real person is given a modern statement, decision or health fact; the writer who marked the grave is living and is not named. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-06-01 Progress note 05 (C-CDA) | Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesium | One to two weeks after starting or changing a diuretic, SGLT2 inhibitor or MRA; then every three to six months | The panel due one to two weeks after spironolactone was started was missed: the bus route to the laboratory changed and she had no ride. The first check came at the sick visit six weeks after the start: potassium 4.4 mmol/L, with creatinine 1.10 mg/dL from volume depletion in the heat, not from the potassium. No harm from the missed check is evident: no hyperkalemia at six weeks or today. Corrective action: laboratory tests on clinic visit days where possible, and rides through the county's transportation program for any separate trip |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-03-23 Progress note 02 (C-CDA) | Laboratory | Lipid panel | Ordered | LDL 132 mg/dL at intake; atorvastatin started today; panel due in four to twelve weeks |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Breast cancer screening (mammogram) | Ordered | Every two years from 40 to 74; none in many years; mammogram booked at the hospital's mobile unit, which comes to her neighborhood |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | Age 45 to 75; never screened; a stool immunochemical (FIT) kit given today, to return by mail, avoiding a trip and bowel preparation |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Bone density (DXA) | Ordered | Recommended for women 65 and older; no prior scan |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested; blood drawn today, result by telephone |
| 2026-09-14 Progress note 06 (C-CDA) | Prevention | Eye examination | Referred | Optometry for a dilated medical eye examination for hypertensive retinopathy, covered by Medicare Part B, with the Medicare Savings Program paying her share |
None.
None.
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-03-09 | NT-proBNP | 480 pg/mL (high) | High |
| 2026-03-09 | Total cholesterol | 212 mg/dL (high) | High |
| 2026-03-09 | LDL cholesterol | 132 mg/dL (high) | High |
| 2026-03-23 | Left atrial volume index | 38 mL/m² (high) | High |
| 2026-03-23 | Mitral E/e' ratio (average) | 15 (high) | High |
| 2026-04-06 | Potassium | 3.4 mmol/L (low) | Low |
| 2026-05-18 | Creatinine | 1.1 mg/dL (high) | High |
| 2026-05-18 | eGFR (CKD-EPI 2021) | 55 mL/min/1.73 m² (low) | Low |